Jan 18, 2025, 14:00 | Insight

2025 Transatlantic Exchange by Dana-Farber and Gustave Roussy to Focus on Radioligand Therapy

Dana-Farber Cancer Institute and Gustave Roussy (Villejuif, France) have announced the 2025 Transatlantic Exchange scientific…

Jan 15, 2025, 14:33 | Blog

The Fourth Transatlantic Exchange in Oncology - Gustave Roussy

Gustave Roussy shared a post on X: "This conference is part of a collaborative agreement…

Jan 13, 2025, 11:50 | Oncolibrary,Oncologist Near Me

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Welcome to OncoDaily’s special section “Oncologist Near Me”, where we introduce prominent oncologists from around…

Jan 9, 2025, 13:27 | Blog

Excellence to cure cancer - Gustave Roussy

Gustave Roussy shared a post on LinkedIn: "Excellence to cure cancer. Gustave Roussy brings together…

Dec 19, 2024, 21:22 | Opinion

Inspiring lecture on the journey of ADCs by Raffaele Colombo at Gustave Roussy - Gustave Roussy

Gustave Roussy shared a post on X: “Outstanding and truly inspiring lecture on the journey…

Dec 17, 2024, 21:24 | Blog

Sabah Z.: Initiatives bring warmth and comfort to care pathways

Sabah Z., Training/Documentation Project Manager at the National Solidarity Fund for Autonomy, posted the following…

Dec 17, 2024, 21:00 | Blog

Toni Choueiri: The 4th Transatlantic Exchange in Oncology between Gustave Roussy and Dana-Farber

Toni Choueiri, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, posted…

Dec 17, 2024, 01:41 | Blog

Gustave Roussy's Christmas tale with “A True Story”

Gustave Roussy shared a post on LinkedIn: "We have never healed from cancer as much…

Dec 5, 2024, 07:39 | Blog

Clarivate Analytics Highly Cited Researchers 2024 - Paris-Saclay University

Paris-Saclay University shared a post on X: "Clarivate Analytics Highly Cited Researchers 2024: 24 of…

Nov 29, 2024, 17:01 | Blog

University Hospital Cologne and Gustave Roussy launched Franco-German research project on lung cancer

The University Hospital of Cologne and the French comprehensive cancer center Gustave Roussy launched a…

Nov 17, 2024, 23:54 | Opinion

David Planchard: Happy to see our young Gustave Roussy - lung oncologists

David Planchard, Head of Thoracic Oncology Group at Gustave Roussy, shared on LinkedIn: "Happy to…

Nov 11, 2024, 15:51 | Blog

Florian Scotté: A new run by Laetitia for The MASCC and Gustave Roussy to the end of the world

Florian Scotté, Head of the Interdisciplinary Patient Pathway Organization Department (DIOPP) at Gustave Roussy, posted on…

Nov 10, 2024, 03:29 | Insight

Harold J. Burstein: Anthracyclines in Early Breast Cancer - The Long Goodbye

Harold J. Burstein, Breast Cancer Specialist and Professor at Harvard Medical School, shared a recent…

Nov 3, 2024, 12:59 | Insight

Uromigos Live24 panel on novel ADCs in urothelial carcinoma

Uromigos shared a post on X: “Don't get spooked by new data - watch the…

Oct 17, 2024, 11:40 | Blog

Isabelle Villadary: Hackathon dedicated to childhood cancer

Isabelle Villadary shared a post by Imagine for Margo - Children without Cancer on LinkedIn,…

Oct 12, 2024, 19:36 | Insight

5 Year Results of the Hypo-FLAME Trial

Alizée Camps Maléa, Radiation oncologist at Gustave Roussy and President of the French Society of…

Oct 6, 2024, 17:18 | Blog

Wafik S. El-Deiry: Honored and grateful for the opportunity to work with Razelle Kurzrock

Wafik S. El-Deiry posted the following on LinkedIn: “Honored and grateful for the opportunity to…

Sep 21, 2024, 13:44 | Blog

MD Anderson named as the World's Best Specialized Hospital for oncology care

Newsweek announced the list of World's Best Specialized Hospitals 2025. After analysis, the top 300…

Sep 19, 2024, 16:38 | Blog

Benjamin Besse: Impressive benefit for Lenvatinib-Pembrolizumab in patients with thymic carcinoma and B3 thymoma

Estela Rodriguez shared a post by Benjamin Besse, Head of Clinical Research at Gustave Roussy,…

Sep 18, 2024, 16:38 | Insight

Pierre Blanchard: The molecular analysis of the PEACE 1 trial

Pierre Blanchard, Radiation Oncology Clinical section chief at Gustave Roussy Cancer Institute, shared on X: "Dr Pobel…

Sep 12, 2024, 09:59 | Insight

Doxorubicin–Trabectedin with Trabectedin maintenance in Leiomyosarcoma

Vivek Subbiah shared a post on X about a recent paper by Patricia Pautier et al., commenting: “Doxorubicin–Trabectedin…

Aug 22, 2024, 15:06 | Insight

Elias Karam: The ultimate dilemma of corticosteroids and Immunotherapy

Elias Karam, Hematology and Medical Oncology Fellow at Gustave Roussy, shared a post on LinkedIn about…

Aug 19, 2024, 09:57 | Insight

3rd line treatments in pancreatic cancer

Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X about a…

Aug 11, 2024, 11:56 | Blog

Florian Scotté: Mascc and Gustave Roussy support Lety and Olivier around the world

Florian Scotté, Head of the Interdisciplinary Patient Pathway Organization Department (DIOPP) at Gustave Roussy, posted on…

Aug 9, 2024, 18:04 | Insight

Meyer May-Lucie: New publication in The Lancet reviewing the treatment of advanced lung cancer

Meyer May-Lucie, Doctor at Gustave Roussy, shared on X about a recent paper titled "New…

Jul 13, 2024, 12:22 | Insight

Key Highlights from KCRS24 by Sumanta K. Pal

Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in Boston focused…

Jul 13, 2024, 11:17 | Blog

David Planchard: New option in the 1st line strategy for NSCLC EGFRmut patients

David Planchard, Thoracic Oncologist at Gustave Roussy, shared on LinkedIn: "Great news, a new option…

Jul 3, 2024, 17:29 | Blog

Benjamin Besse: Stop pembro after 2 years?

Benjamin Besse, Head of Clinical Research at Gustave Roussy, shared on X: "Stop pembro after…

Jul 3, 2024, 10:28 | Societies

Florian Scotté: Thanks to our partners for the 2024 MASCC-AFSOS-ISOO meeting

Florian Scotté, Head of the Interdisciplinary Patient Pathway Organization Department (DIOPP) at Gustave Roussy, posted on…

Jul 2, 2024, 13:38 | Insight

Yan Pei-Ming gives a face to the Institute with a monumental portrait of Professor Gustave Roussy

Gustave Roussy shared a post on LinkedIn: ,…

Jun 30, 2024, 12:02 | Blog

Improving quality of life after breast cancer treatment

Gary L. Thompson, Board Chair of Side-Out Foundation, shared on X: "Day 199/262 of my 'tour'…

Jun 30, 2024, 08:07 | Societies

9 Posts You Should Not Miss From Day 3 of ESMOGI24!

ESMOGI24 is taking place as an onsite event in Munich, Germany, from 26 to 29 June 2024,…

Jun 29, 2024, 13:12 | Societies

Poster on early-onset CCA won Best Poster at ESMOGI24

Natalia Tissera, PhD Student at Vall d'Hebron Institute of Oncology (VHIO), shared on X: "Thrilled…

Jun 29, 2024, 06:20 | Societies

Gustave Roussy received the renewal of the MASCC Center of Excellence Certification

Florian Scotté, Head of the Interdisciplinary Department for Organization of Patient Pathways (DIOPP) at Gustave…

Jun 28, 2024, 14:22 | Blog

Julia Lai-Kwon: Enjoyed a pre MASCC24 visit to Gustave Roussy

Julia Lai-Kwon, Medical Oncologist and PhD candidate at Peter Mac Cancer Centre, recently shared a…

Jun 28, 2024, 04:59 | Blog

Mihaela Aldea received a 2024 IASLC YIA

Mihaela Aldea, Medical Oncologist at the Gustave Roussy, shared a post on X: "Honored to…

Jun 27, 2024, 14:15 | Blog

David Planchard: Nice post-ASCO24 at Gustave Roussy with the lung session

David Planchard shared on LinkedIn: "Nice post-ASCO24 Gustave Roussy with the lung session. What wonderful…

Jun 21, 2024, 07:47 | Blog

Blood Cancers Today - Is reduced-duration venetoclax in AML effective?

Blood Cancers Today shared a post on X: "Is reduced-duration venetoclax in AML effective? A study…

Jun 9, 2024, 08:43 | Insight

Daniel Stover: Activity post-breast cancer diagnosis: Is ‘exercise’ just ‘exercise’?

Daniel Stover, Medical Oncologist and Computational Biologist at Ohio State University Comprehensive Cancer Center, shared…

Jun 2, 2024, 12:19 | Blog

Ines Vaz Luis: Such an honor to receive a mentorship award

Ines Vaz Luis, Director of Cancer Survivorship Research Group at Gustave Roussy, shared a post…

May 23, 2024, 14:25 | Insight

Benjamin Besse: Should we infuse IO in the morning?

Benjamin Besse, Head of Clinical Research on Gustave Roussy, shared on X: "Should we infuse…

May 15, 2024, 14:44 | Blog

Maria Babak: Welcome to our May edition of Babak Monthly!

Maria Babak, Head of Drug Discovery Lab at City University of Hong Kong, shared a post…

May 14, 2024, 16:52 | Insight

Fabrice Andre: This risk-based approach is the foundation of modern cancer prevention centers

Fabrice Andre, Head of Research Division at Gustave Roussy, shared on X: "In this review ⁦of…

May 10, 2024, 14:48 | Blog

Rémi Thiolet: Gustave Roussy had the honor to meet the PM of Egypt and Minister of Health and Population

Rémi Thiolet, International advisor and Head of International Affairs at Gustave Roussy, shared on LinkedIn:…

May 5, 2024, 22:37 | Opinion

Vivek Subbiah: A story of meeting with a legend

Vivek Subbiah shared a post on LinkedIn: “Sharing a story of meeting with a legend ……

May 2, 2024, 23:11 | Blog

Vivek Subbiah: My first time inside Gustave Roussey in Paris France

Vivek Subbiah shared a post on LinkedIn: “My first time inside Gustave Roussey in Paris France.…

May 2, 2024, 14:25 | Insight

Fabrice Andre: A nice seminar around Precision Medicine

Vivek Subbiah shared a post by Fabrice Andre, Head of Research Division at Gustave Roussy…

May 1, 2024, 20:07 | Blog

Vivek Subbiah: Looking forward to delivering the keynote at the esteemed PRISM center in Paris

Vivek Subbiah shared a post on LinkedIn: “Just landed in Paris! Looking forward to delivering…

May 1, 2024, 10:06 | Insight

David Planchard: Proud to present 1st results of ICARUS-Lung 01 study

David Planchard, Professor at the University of Paris-Saclay, posted on LinkedIn: “Superb oral session on…

Apr 30, 2024, 14:56 | Blog

Fabrice Andre: ESMO is launching a monthly virtual journal club

Fabrice Andre, Head of Research Division at Gustave Roussy and President-Elect at ESMO, shared on…

Apr 26, 2024, 12:00 | Blog

Vivek Subbiah: Window of opportunity (WOO) studies across cancer subtypes by Barbara Pistilli

Vivek Subbiah shared a post on X/Twitter: "Window of opportunity (WOO) studies across cancer subtypes?…

Apr 26, 2024, 08:52 | Blog

Yuksel Urun: A brilliant perspective and a lesson-laden approach from Bernard Escudier, Gustave Roussy

Yuksel Urun, Professor in Department of Medical Oncology at Ankara University School of Medicine, shared…

Apr 17, 2024, 10:09 | Positive

Yaniss B.: The 3rd edition of the Transatlantic Exchanges in Oncology was a huge success!

Yaniss B, Valorisation Officer at Gustave Roussy Transfert shared on X: “The 3rd edition of the…

Apr 16, 2024, 13:22 | Blog

Toni Choueiri: And that is a wrap for the Transatlantic conference between Dana-Farber, Gustave Roussy

Toni Choueiri shared on their X/Twitter: ''And that is a wrap for the Transatlantic conference…

Apr 16, 2024, 12:58 | Drugs

Emre Yekedüz: A retrospective study from Gustave Roussy

Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University and Research Fellow at Dana-Farber Cancer…

Apr 16, 2024, 02:27 | Blog

Dana-Farber Cancer Institute and Gustave Roussy are proud to share their progress in cancer treatment

Gustave Roussy shared on X/Twitter: "Launch of the Third Transatlantic exchange in Oncology in Boston. Dana-Farber…

Apr 6, 2024, 10:04 | Drugs

Jean Zeghondy: Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open

Jean Zeghondy, Associate Practitioner at the Breast Cancer Unit at Gustave Roussy, shared a post…

Feb 27, 2024, 19:03 | Blog

Humaid Al-Shamsi: We had the pleasure to share our experience with Prof. Planchard in treating 10 complex lung cancer cases

Humaid Al-Shamsi, Director of Burjeel Cancer Institute (BCI), posted on LinkedIn: "With Prof. David Planchard…

Feb 22, 2024, 10:58 | Blog

Toni Choueiri: The 3rd transatlantic exchanges between Dana-Farber Cancer Institute and Gustave Roussy happening on April 12

Toni Choueiri, Senior Executive and Chief of Genitourinary Cancers at Dana-Farber Cancer Institute, shared a…

Feb 20, 2024, 15:58 | Blog

Fabrice Barlesi: Gustave Roussy's new building will form part of the largest cancer campus in France

Fabrice Barlesi, Chief Executive Officer at Gustave Roussy, shared on LinkedIn: "To boost its research…

Dec 30, 2023, 04:35 | Insight

Antonin Marchais: A publication full of hope for improving the management of osteosarcoma

Antonin Marchais, Researcher and Leader of the Osteosarcoma Research Group at Gustave Roussy, shared on LinkedIn:…

Nov 28, 2023, 16:24 | Blog

Elsa Bernard: Very happy to join Gustave Roussy to lead a Computational Clinical Oncology group!

Elsa Bernard, a Visiting Research Scientist at The Francis Crick Institute, recently shared on X/Twitter:…

Sep 22, 2023, 18:44 | Blog

Brian Alexander: Excited about our new collaboration with Gustave Roussy and Roche France to bring liquid biopsy genomic testing to patients in France.

Brian Alexander, CEO of Foundation Medicine, shared on LinkedIn: "Excited about our new collaboration with…

Sep 12, 2023, 20:05 | Insight

Benjamin Besse: Time to change our practice and give our IOs in the morning?

Benjamin Besse, Head of Clinical Research at Gustave Roussy, shared on Twitter: "Accumulative publications showing…

Aug 22, 2023, 09:53 | Blog

David Planchard: Amphitheater full, impressive and top organization by the ESMO staff.

Quoting David Planchard, Thoracic Oncologist and Head of Thoracic Cancer Group at Gustave Roussy, stated…

Aug 16, 2023, 18:57 | Insight

Pablo Berlanga Charriel: It is a pleasure to announce that the first results of the SACHA France study have recently been published.

Pablo Berlanga Charriel, Pediatric Oncology Consultant at Gustave Roussy, recently shared on LinkedIn: "It is…

Jul 21, 2023, 18:38 | Positive

A milestone was achieved last week at Gustave Roussy radiotherapy department - Eric Deutsch

A milestone was achieved last week at Gustave Roussy radiotherapy department with the arrival of the…